Cardiovascular Diabetology
JUNE 6, 2025
Heart failure with preserved ejection fraction (HFpEF) poses a significant global health challenge, disproportionately affecting women. Diabetic women with HFpEF represent a high-risk subgroup, particularly af.
Med Page Today
JUNE 6, 2025
(MedPage Today) -- A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. Following a review of all available data, the.
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Medical Xpress - Cardiology
JUNE 6, 2025
A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according to research presented Tuesday at the British Cardiovascular Society conference in Manchester.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
American College of Cardiology
JUNE 6, 2025
In this episode, Drs. Jenna Skowronski, Francesco Castagna and Saraschandra Vallabhajosyula unpack how assumptions drawn from ST-segment elevation myocardial infarction (STEMI) data may be leading us astray in broader shock management.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
The New England Journal of Medicine
JUNE 6, 2025
A 76-year-old retired cardiovascular nurse presented to the ED with 2 hours of chest pain triggered by severe emotional distress and associated with changes in the electrocardiogram on her smartwatch.
CardiacWire
JUNE 6, 2025
New ACC registry data suggests interventional cardiologists are using less contrast for PCI procedures in the cath lab which helps reduce post-PCI acute kidney injury risks, but a deeper look tells us there’s still room for improvement. Iodinated contrast agents are commonly used for PCI with gadolinium-based contrast serving as an alternative but both can cause complications like acute kidney injury.
HCPLive
JUNE 6, 2025
New research has indicated that glucagon-like peptide-1 receptor agonists result in lower all-cause mortality and risk of cardiovascular events in patients with concurrent sleep apnea and type 2 diabetes.
Frontiers in Cardiovascular Medicine
JUNE 6, 2025
BackgroundGuideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (HFrEF) has been demonstrated to significantly reduce morbidity and mortality. However, many patients, especially those with advanced HFrEF, are unable to tolerate optimal GDMT due to hypotension. Cardiac contractility modulation (CCM) is a novel therapeutic approach that enhances myocardial contractility and reverses cardiac remodeling, thereby improving cardiac function and quality of life
DAIC
JUNE 6, 2025
tim.hodson Fri, 06/06/2025 - 14:01 June 6, 2025 – A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events and inpatient admissions. This is the first retrospective trial to evaluate the clinical impact of GLP-1 RAs for patients with moderate PAD.
Frontiers in Cardiovascular Medicine
JUNE 6, 2025
BackgroundThe triglyceride-glucose (TyG) index, a simple surrogate marker of insulin resistance (IR), has been associated with cardiovascular risk factors and atherosclerosis. However, its relationship with carotid atherosclerosis (CA), including carotid intima thickening (CMT), plaques, and stenosis, remains inadequately studied in the general population.PurposeThis study aimed to evaluate the association between the TyG index and CA.MethodsA retrospective cross-sectional study was conducted am
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Frontiers in Cardiovascular Medicine
JUNE 6, 2025
IntroductionAtrial fibrillation (AF) is a well-established contributing factor to isolated tricuspid regurgitation (TR), with elevated left atrial pressure (LAP) playing a crucial role in disease progression and patient outcomes. We investigated the relationship between LAP and TR in patients with AF.MethodsWe enrolled individuals diagnosed with AF who underwent LA appendage closure at two centers in China, between January 2015 and December 2023.
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Frontiers in Cardiovascular Medicine
JUNE 6, 2025
IntroductionBlood pressure follows a circadian rhythm and is influenced by various factors. Blood pressure rises in the morning and decreases at night. It is known that deviations from this pattern are associated with an increased cardiovascular risk. Therefore, it is important to analyze blood pressure profiles and blood pressure variability.MethodsA blood pressure model was developed based on data from cuffless blood pressure measurements of six healthy volunteers over a 14-day period.
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Frontiers in Cardiovascular Medicine
JUNE 6, 2025
BackgroundPregnant women experience various physiological changes that, if uncompensated, may result in varying degrees of cardiac dysfunction, and adverse pregnancy outcomes. Left ventricular (LV) global longitudinal strain (GLS) and P-wave to A' duration on tissue Doppler imaging (PA-TDI) have been shown to be able to detect subtle cardiac dysfunction.MethodsThe present study was a prospective cross-sectional study.
HCPLive
JUNE 6, 2025
A panelist discusses how successful treatment requires selecting the right three to five medications with minimal side effects, using once-daily combination pills to maximize adherence, and engaging patients as active participants through structured home blood pressure monitoring protocols.
Cardiovascular Diabetology
JUNE 6, 2025
Atrial fibrillation (AF) frequently coexists with diabetes mellitus (DM), leading to a worse prognosis if both are present. Steatotic liver disease (SLD) may also predispose to DM, but its impact among AF pati.
HCPLive
JUNE 6, 2025
A panelist discusses how patient compliance remains the primary obstacle to blood pressure control despite effective medications being available, while clinical inertia among healthcare providers and medication side effects affecting electrolytes and kidney function add additional complexity to resistant hypertension management.
The American Journal of Cardiology
JUNE 6, 2025
Publication date: Available online 5 June 2025 Source: The American Journal of Cardiology Author(s): Kota Murai, Kensuke Takagi, Fumiyuki Otsuka, Yoshiyuki Tomishima, Takamasa Iwai, Kenichiro Sawada, Hideo Matama, Satoshi Honda, Masashi Fujino, Shuichi Yoneda, Kazuhiro Nakao, Yu Kataoka, Yasuhide Asaumi, Kisaki Amemiya, Manabu Matsumoto, Keiko Ohta-Ogo, Yoshihiko Ikeda, Hatsue Ishibashi-Ueda, Kinta Hatakeyama, Teruo Noguchi
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
The American Journal of Cardiology
JUNE 6, 2025
Publication date: Available online 6 June 2025 Source: The American Journal of Cardiology Author(s): Deniz Mutlu, Ozgur Selim Ser, Dimitrios Strepkos, Pedro E.P. Carvalho, Michaella Alexandrou, Barkin Kultursay, Ali Karagoz, Oleg Krestyaninov, Dmitrii Khelimskii, Mahmut Uluganyan, Korhan Soylu, Ufuk Yildirim, Mehmet Semih Belpinar, Olga Mastrodemos, Bavana V.
HCPLive
JUNE 6, 2025
Semaglutide’s reduction in systolic blood pressure could indicate more potential for cardiovascular protection than simply its well-known glycemic benefits.
Circulation: Arrhythmia and Electrophysiology
JUNE 6, 2025
Circulation: Arrhythmia and Electrophysiology, Ahead of Print.
HCPLive
JUNE 6, 2025
A panelist discusses how dual orexin receptor antagonists (DORAs) are considered a first-line treatment for chronic insomnia, particularly for sleep maintenance issues, due to their superior tolerability, lack of withdrawal symptoms, and positive impact on daytime functioning.
Frontiers in Cardiovascular Medicine
JUNE 6, 2025
BackgroundParacentral acute middle maculopathy (PAMM) is a rare, presumed ischemic maculopathy. While primarily associated with retinal vascular pathologies, several case studies have documented PAMM diagnoses following systemic cardiovascular events or interventions. Here, we discuss a case of PAMM development after carotid artery dissection (CAD).Case presentationA woman in her late 30 s presented to the emergency department with transient right-side weakness and amaurosis in her left eye last
HCPLive
JUNE 6, 2025
A panelist discusses how dual orexin receptor antagonists (DORAs) are ideal for patients with chronic insomnia who require long-term sleep support, emphasizing their safety, tolerability, and effectiveness, while cautioning against use in patients with narcolepsy, parasomnia history, or severe kidney or liver disease.
Dr. Paddy Barrett
JUNE 6, 2025
Over a long enough time horizon, everyone will develop coronary artery disease. It is not a matter of if but when. The ultimate goal, even when doing everything right, is to die at an old age having lived a long and healthy life ‘ with ’, but not ‘ from ’ coronary artery disease. In general, heart disease doesn’t kill people.
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Frontiers in Cardiovascular Medicine
JUNE 6, 2025
AimTo carry out a nationwide evaluation of both in- and out-of-hospital mortality for acute myocardial infarction (AMI) during the COVID-19 pandemic period in Italy.MethodsThis was a retrospective cohort study analysing overall mortality for AMI in Italy during the COVID-19 pandemic (March 1st, 2020–December 31st, 2021) and the previous 5 years (January 1st, 2015–February 29th, 2020).
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Medical Xpress - Cardiology
JUNE 6, 2025
New research from the University of Minnesota Medical School demonstrates that using cardiovascular magnetic resonance imaging—known as CMR phenotyping—can help identify patients with suspected cardiac sarcoidosis who are at increased risk of sudden cardiac death.
HCPLive
JUNE 6, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Med Page Today
JUNE 6, 2025
(MedPage Today) -- Though stroke mortality has decreased over the last few decades, there is still room for improvement, researchers said. Using global data on stroke mortality and risk factors as recent as 2021, age-standardized death rates were.
Expert insights. Personalized for you.
121 
Let's personalize your content